论文部分内容阅读
采用乙肝疫苗治疗100例 HBsAg 携带者,并以30例对照。实验组 HBsAg 阴转率17.0%,对照组阴转率13.3%(P>0.05);实验组 Anti—HBs 阳转率11.0%,对照组Anti—HBs 阳转率3.3%(P>0.05)。
Hepatitis B vaccine treatment of 100 cases of HBsAg carriers, and 30 cases of control. In the experimental group, the negative conversion rate of HBsAg was 17.0% in the control group and 13.3% in the control group (P> 0.05). The positive conversion rate of Anti-HBs was 11.0% in the experimental group and 3.3% (P> 0.05).